Shadman, M., Thompson, P., Heyman, B., Hutchings, M., Lori, L. A., Yuda, J., Zinzani, P. L., Colton, D., Hoehn, D., Izuzquiza, M., Mato, A., Gorgun, G., Chen, R. W., Kuruvilla, J. (2025). TITANium: An open-label, global multicenter phase 1/2 study of AZD5492, a first-in-class subcutaneous CD8-guided tri-specific T-cell engager (TCE), in patients (pts) with relapsed or refractory (r/r) B-cell malignancies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps7091